• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

immunotherapy

AZ
Pharma

AZ's Imfinzi bags perioperative OK in early-stage stomach cancer

The FDA signed off on Imfinzi as the first immunotherapy that can treat certain patients with early-stage stomach cancer before and after surgery.
Zoey Becker Nov 25, 2025 4:55pm
Gavel

Amgen gets some relief in Blincyto patent feud with Lindis

Aug 15, 2025 10:13am
FDA Building

FDA limits Keytruda, Opdivo uses in stomach cancer

Jun 9, 2025 10:50am
Imfinzi

ASCO: AZ looks to bring immunotherapy to early stomach cancer

Jun 1, 2025 8:00am
Close up of horse legs and hooves running on sand track

J&J puts ImmunityBio on defense mode in bladder cancer

Apr 27, 2025 12:35pm
Gilead

Gilead's Trodelvy-Keytruda proposal hits goal in first-line TNBC

Apr 21, 2025 11:29am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings